目的:探讨寻常型银屑病中医证型与血清miR-155、转化生长因子β1(TGF-β1)、银屑病皮损面积及严重程度指数(PASI)评分相关性研究。方法:回顾性选取2021年9月~2023年9月北京中医药大学东直门医院收治120例的寻常型银屑病患者为研究对象...目的:探讨寻常型银屑病中医证型与血清miR-155、转化生长因子β1(TGF-β1)、银屑病皮损面积及严重程度指数(PASI)评分相关性研究。方法:回顾性选取2021年9月~2023年9月北京中医药大学东直门医院收治120例的寻常型银屑病患者为研究对象。统计寻常型银屑病中医证型分布情况,比较不同中医证型患者血清miR-155、TGF-β1水平及PASI评分,分析寻常型银屑病中医证型与血清miR-155、TGF-β1水平与PASI评分的关系。结果:120例寻常型银屑病患者中血热证51例、血瘀证38例、血燥证31例;不同中医证型寻常型银屑病患者血清miR-155、TGF-β1水平及PASI评分为血热证>血瘀证>血燥证( P <0.05);寻常型银屑病患者血清miR-155、TGF-β1水平与PASI评分呈正相关(r=0.649、 P <0.05,r=0.676、 P <0.05)。结果:寻常型银屑病中医证型与血清miR-155、TGF-β1水平及PASI评分具有良好的相关性,可以为寻常型银屑病患者辨证施治提供指导。展开更多
Objective To investigate the effects of acitretin on T helper cell(Th)1/Th2 balance and Th17 cells in psoriasis vulgaris(PV)patients.Methods A total of 13 men and 17 women with PV were investigated.10 mg of acitretin ...Objective To investigate the effects of acitretin on T helper cell(Th)1/Th2 balance and Th17 cells in psoriasis vulgaris(PV)patients.Methods A total of 13 men and 17 women with PV were investigated.10 mg of acitretin was administered twice a day for 8 weeks for intervention therapy.Serum levels of interferon-gamma(IFN-γ),interleukin(IL)-4 and IL-17 were measured by enzyme-linked immunosorbent assay.T,Th1,Th2 and Th17 cells in skin biopsies were counted with double-labeled immunofluorescence.Psoriasis Area and Severity Index(PASI)score was calculated before and 8 weeks after treatment.Results Before treatment PV patients had higher serum levels of IFN-γ and IL-17,and increased T,Th1 and Th17 cells in skin biopsies.After treatment,both serum levels of IFN-γ and IL-17,and T,Th1 and Th17 cells infiltrating in PV skin decreased significantly.Th1/Th2 balance was restored to normal.However,their IL-4 and Th2 cells showed no significant change throughout the therapy.Conclusion Acitretin exerts influence on dermal Th1/Th2 balance and Th17 cell infiltration,so does it on production of systematic inflammatory cytokines IFN-γ and IL-17 in PV patients.However,Th2 cells and its derivative cytokine—IL-4 are not affected.展开更多
目的:观察中药消疕合剂对寻常型银屑病血热证的影响,比较银屑病皮损面积和严重性指数(Psoriasis Area and Severity Index,PASI)评分及血清血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)水平变化。方法:将90例入组患者随...目的:观察中药消疕合剂对寻常型银屑病血热证的影响,比较银屑病皮损面积和严重性指数(Psoriasis Area and Severity Index,PASI)评分及血清血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)水平变化。方法:将90例入组患者随机分成两组:治疗组50例口服消疕合剂,每次125 mL,每天2次;对照组40例口服消银颗粒,每次1包,每天3次,共观察8周。治疗组治疗前后检测外周血VEGF水平。结果:治疗组治疗后PASI评分明显低于对照组,差异有统计学意义(P<0.05),有效率优于对照组,差异有统计学意义(P<0.05);治疗组治疗后血清VEGF水平均较治疗前显著降低,差异有统计学意义(P<0.001)。结论:中药消疕合剂可显著降低寻常型银屑病血热证患者PASI指数,其机理可能与其降低患者血清VEGF水平有关。展开更多
目的分析皮损组织Cx26蛋白含量及信使RNA表达与寻常型银屑病(PV)患者皮损面积和严重程度指数(psoriasis area and severity index,PASI)评分的关联性。方法2018年7月-2019年7月选取本院PV患者60例作为研究组,另选同期健康体检者32例作...目的分析皮损组织Cx26蛋白含量及信使RNA表达与寻常型银屑病(PV)患者皮损面积和严重程度指数(psoriasis area and severity index,PASI)评分的关联性。方法2018年7月-2019年7月选取本院PV患者60例作为研究组,另选同期健康体检者32例作为对照组,分析皮损组织Cx26蛋白、信使RNA水平与PV患者PASI评分的关联性。结果研究组Cx26蛋白含量及信使RNA表达水平均高于对照组(P<0.05);研究组轻度患者Cx26蛋白含量及信使RNA表达水平低于中度,中度患者Cx26蛋白含量及信使RNA表达水平低于重度(P<0.05);经Spearman分析可知,PASI评分与Cx26蛋白含量(r=0.625)及信使RNA表达水平(r=0.541)存在明显正相关关系(P<0.05)。结论PV患者Cx26蛋白含量及信使RNA表达水平与PASI评分密切相关,可作为评判疾病进展、预后指标,为临床治疗提供指导依据。展开更多
Objective:Up to 85.3%of patients with psoriasis experience sleep disturbance(SD).However,SD has not been characterized in Chinese patients with psoriasis,and the factors that affect SD among adult patients with psoria...Objective:Up to 85.3%of patients with psoriasis experience sleep disturbance(SD).However,SD has not been characterized in Chinese patients with psoriasis,and the factors that affect SD among adult patients with psoriasis remain unclear.This study was performed to examine the risk of SD in patients with psoriasis compared with a control group of healthy individuals and to identify factors contributing to SD in patients with psoriasis.Methods:This was a cross-sectional,questionnaire-based,case-control study involving 142 adult participants with psoriasis and 142 healthy controls.The Pittsburgh Sleep Quality Index(PSQI)was administered to assess SD.Mild psoriasis was defined by Psoriasis Area and Severity Index and body surface area cut-offs of<10,and mild to severe psoriasis was determined by Psoriasis Area and Severity Index and body surface area cut-offs of≥10.Logistic regression was performed to investigate the associations.Results:The prevalence of SD(PSQI score of≥6)was 47.9%in adult patients with psoriasis.The mean PSQI score in patients with psoriasis was 6.1±3.7,which was higher than that in the control group(4.9±2.5,P<0.001).The risk of SD in the psoriasis group was 1.669 times higher(95%confidence interval,1.008-2.761;P=0.046)than that in the healthy group.Female sex(adjusted odds ratio,4.130;95%confidence interval,1.306-13.058;P=0.016)was significantly associated with an increased risk of SD in patients with moderate to severe psoriasis,whereas there were no significant factors affecting the risk of SD in patients with mild psoriasis.Conclusion:Patients with psoriasis were more likely than healthy controls to develop SD.In patients with moderate to severe psoriasis,but not in those with mild psoriasis,female sex was associated with a higher likelihood of SD.展开更多
目的观察百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗斑块状银屑病的临床疗效。方法将162例斑块状银屑病患者分为试验组(82例)和对照组(80例),试验组采用百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗,对照组采用阿维A胶囊联...目的观察百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗斑块状银屑病的临床疗效。方法将162例斑块状银屑病患者分为试验组(82例)和对照组(80例),试验组采用百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗,对照组采用阿维A胶囊联合复方氟米松软膏治疗,持续8周,治疗前、治疗4周和治疗8周后分别进行银屑病面积与严重指数(psoriasis area and severity index,PASI)测评,观察并比较两组临床疗效。结果治疗4周和8周后,两组PASI均较治疗前显著降低(P<0.01),且试验组PASI降低程度均显著大于对照组(P<0.01);治疗4周和8周后,试验组临床疗效均显著优于对照组(P<0.05)。结论在阿维A胶囊、复方氟米松软膏联合治疗的基础上再联用百癣夏塔热胶囊可明显提高斑块状银屑病的临床疗效。展开更多
文摘目的:探讨寻常型银屑病中医证型与血清miR-155、转化生长因子β1(TGF-β1)、银屑病皮损面积及严重程度指数(PASI)评分相关性研究。方法:回顾性选取2021年9月~2023年9月北京中医药大学东直门医院收治120例的寻常型银屑病患者为研究对象。统计寻常型银屑病中医证型分布情况,比较不同中医证型患者血清miR-155、TGF-β1水平及PASI评分,分析寻常型银屑病中医证型与血清miR-155、TGF-β1水平与PASI评分的关系。结果:120例寻常型银屑病患者中血热证51例、血瘀证38例、血燥证31例;不同中医证型寻常型银屑病患者血清miR-155、TGF-β1水平及PASI评分为血热证>血瘀证>血燥证( P <0.05);寻常型银屑病患者血清miR-155、TGF-β1水平与PASI评分呈正相关(r=0.649、 P <0.05,r=0.676、 P <0.05)。结果:寻常型银屑病中医证型与血清miR-155、TGF-β1水平及PASI评分具有良好的相关性,可以为寻常型银屑病患者辨证施治提供指导。
基金supported by the Science Technology Research and Development Program of Shaanxi Province of China.(No.2008K15-06(14))Research Fund for the Doctoral Programof Higher Education of China(No.20070698071)
文摘Objective To investigate the effects of acitretin on T helper cell(Th)1/Th2 balance and Th17 cells in psoriasis vulgaris(PV)patients.Methods A total of 13 men and 17 women with PV were investigated.10 mg of acitretin was administered twice a day for 8 weeks for intervention therapy.Serum levels of interferon-gamma(IFN-γ),interleukin(IL)-4 and IL-17 were measured by enzyme-linked immunosorbent assay.T,Th1,Th2 and Th17 cells in skin biopsies were counted with double-labeled immunofluorescence.Psoriasis Area and Severity Index(PASI)score was calculated before and 8 weeks after treatment.Results Before treatment PV patients had higher serum levels of IFN-γ and IL-17,and increased T,Th1 and Th17 cells in skin biopsies.After treatment,both serum levels of IFN-γ and IL-17,and T,Th1 and Th17 cells infiltrating in PV skin decreased significantly.Th1/Th2 balance was restored to normal.However,their IL-4 and Th2 cells showed no significant change throughout the therapy.Conclusion Acitretin exerts influence on dermal Th1/Th2 balance and Th17 cell infiltration,so does it on production of systematic inflammatory cytokines IFN-γ and IL-17 in PV patients.However,Th2 cells and its derivative cytokine—IL-4 are not affected.
文摘目的:观察中药消疕合剂对寻常型银屑病血热证的影响,比较银屑病皮损面积和严重性指数(Psoriasis Area and Severity Index,PASI)评分及血清血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)水平变化。方法:将90例入组患者随机分成两组:治疗组50例口服消疕合剂,每次125 mL,每天2次;对照组40例口服消银颗粒,每次1包,每天3次,共观察8周。治疗组治疗前后检测外周血VEGF水平。结果:治疗组治疗后PASI评分明显低于对照组,差异有统计学意义(P<0.05),有效率优于对照组,差异有统计学意义(P<0.05);治疗组治疗后血清VEGF水平均较治疗前显著降低,差异有统计学意义(P<0.001)。结论:中药消疕合剂可显著降低寻常型银屑病血热证患者PASI指数,其机理可能与其降低患者血清VEGF水平有关。
文摘目的分析皮损组织Cx26蛋白含量及信使RNA表达与寻常型银屑病(PV)患者皮损面积和严重程度指数(psoriasis area and severity index,PASI)评分的关联性。方法2018年7月-2019年7月选取本院PV患者60例作为研究组,另选同期健康体检者32例作为对照组,分析皮损组织Cx26蛋白、信使RNA水平与PV患者PASI评分的关联性。结果研究组Cx26蛋白含量及信使RNA表达水平均高于对照组(P<0.05);研究组轻度患者Cx26蛋白含量及信使RNA表达水平低于中度,中度患者Cx26蛋白含量及信使RNA表达水平低于重度(P<0.05);经Spearman分析可知,PASI评分与Cx26蛋白含量(r=0.625)及信使RNA表达水平(r=0.541)存在明显正相关关系(P<0.05)。结论PV患者Cx26蛋白含量及信使RNA表达水平与PASI评分密切相关,可作为评判疾病进展、预后指标,为临床治疗提供指导依据。
基金supported by grants from the National Natural Science Foundation of China(Nos.82073447,81974479,81773329)National key R&D program(No.2018YFC0117004).
文摘Objective:Up to 85.3%of patients with psoriasis experience sleep disturbance(SD).However,SD has not been characterized in Chinese patients with psoriasis,and the factors that affect SD among adult patients with psoriasis remain unclear.This study was performed to examine the risk of SD in patients with psoriasis compared with a control group of healthy individuals and to identify factors contributing to SD in patients with psoriasis.Methods:This was a cross-sectional,questionnaire-based,case-control study involving 142 adult participants with psoriasis and 142 healthy controls.The Pittsburgh Sleep Quality Index(PSQI)was administered to assess SD.Mild psoriasis was defined by Psoriasis Area and Severity Index and body surface area cut-offs of<10,and mild to severe psoriasis was determined by Psoriasis Area and Severity Index and body surface area cut-offs of≥10.Logistic regression was performed to investigate the associations.Results:The prevalence of SD(PSQI score of≥6)was 47.9%in adult patients with psoriasis.The mean PSQI score in patients with psoriasis was 6.1±3.7,which was higher than that in the control group(4.9±2.5,P<0.001).The risk of SD in the psoriasis group was 1.669 times higher(95%confidence interval,1.008-2.761;P=0.046)than that in the healthy group.Female sex(adjusted odds ratio,4.130;95%confidence interval,1.306-13.058;P=0.016)was significantly associated with an increased risk of SD in patients with moderate to severe psoriasis,whereas there were no significant factors affecting the risk of SD in patients with mild psoriasis.Conclusion:Patients with psoriasis were more likely than healthy controls to develop SD.In patients with moderate to severe psoriasis,but not in those with mild psoriasis,female sex was associated with a higher likelihood of SD.
文摘目的观察百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗斑块状银屑病的临床疗效。方法将162例斑块状银屑病患者分为试验组(82例)和对照组(80例),试验组采用百癣夏塔热胶囊联合阿维A胶囊、复方氟米松软膏治疗,对照组采用阿维A胶囊联合复方氟米松软膏治疗,持续8周,治疗前、治疗4周和治疗8周后分别进行银屑病面积与严重指数(psoriasis area and severity index,PASI)测评,观察并比较两组临床疗效。结果治疗4周和8周后,两组PASI均较治疗前显著降低(P<0.01),且试验组PASI降低程度均显著大于对照组(P<0.01);治疗4周和8周后,试验组临床疗效均显著优于对照组(P<0.05)。结论在阿维A胶囊、复方氟米松软膏联合治疗的基础上再联用百癣夏塔热胶囊可明显提高斑块状银屑病的临床疗效。